Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...
In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback